Lower interest rates over the next several years will stifle net interest income growth. The company may have a greater opportunity to recruit advisors as it fills holes in its geographic footprint ...

Elite Pharmaceuticals, with a market capitalization of $531 million, reported a decline in third-quarter revenue for 2024, falling 8% from the previous year. Despite a strong nine-month performance, ...

Read about the appointment of defense tech industry veteran Rob Bocek as chief revenue officer at Virtualitics.

Bio-Rad projects 2025 currency-neutral revenue growth of 1.5%-3.5%, excluding contributions from acquisitions. Diagnostics revenue is expected to grow between 2%-3%, while Life Science revenue is ...

Sony Music Entertainment (SME) achieved double-digit overall growth during 2024’s final three months. But amid industry-wide ...

NetApp is a high-margin, cash-generating company, but has low revenue growth at 1.7% CAGR. Read why I'm neutral on NTAP stock ...